Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

sell
CytoDyn Inc_INT

Start price
Target price
Perf. (%)
€2.10
23.10.20
€1.00
04.11.21
7.62%
04.11.20

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Significant cyclical dependencies
geldnutzer 
23.10.20 50%
buy
Bayer AG

Start price
Target price
Perf. (%)
€42.35
23.10.20
€54.00
04.11.21
17.72%
05.11.21

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
geldnutzer 
23.10.20 50%
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€54.61
23.10.20
€55.00
31.10.20
-8.91%
31.10.20

Known brand
Fair valuation
Leading role in innovation
Future proof or reliable business model
Traumtanz 
23.10.20 50%
buy
Vertex Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€177.98
22.10.20
€170.00
04.11.21
-6.03%
05.11.21

Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Rising EBIT margin expected
geldnutzer 
22.10.20 50%
buy
Thermo Fisher Scientific Inc.

Start price
Target price
Perf. (%)
€406.60
22.10.20
€580.00
04.11.21
37.09%
05.11.21

Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
Rising EBIT margin expected
geldnutzer 
22.10.20 50%
buy
Intuitive Surgical Inc

Start price
Target price
Perf. (%)
€201.33
22.10.20
€216.67
04.11.21
4.35%
07.11.20

Known brand
Future proof or reliable business model
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Traumtanz 
22.10.20 50%
sell
Intercept Pharmaceuticals

Start price
Target price
Perf. (%)
€25.77
21.10.20
-
04.11.21
-36.63%
05.11.21

Risky Investment
Lokrim 
21.10.20 20%
buy
Anavex Life Sciences Corp

Start price
Target price
Perf. (%)
€4.28
21.10.20
€6.00
04.11.21
348.60%
05.11.21

Could be worthwhile Investment >10% per year
melinda 
21.10.20 50%
buy
Misonix Inc.

Start price
Target price
Perf. (%)
€10.30
21.10.20
€12.00
02.11.20
-7.28%
02.11.20

Could be worthwhile Investment >10% per year
DomRuinart 
21.10.20 50%
buy
Hologic Inc.

Start price
Target price
Perf. (%)
€56.50
20.10.20
€60.00
04.11.21
-11.63%
07.06.21

Could be worthwhile Investment >10% per year
melinda 
20.10.20 50%
sell
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€51.42
20.10.20
€50.00
22.10.20
-1.26%
22.10.20

Known brand
Fair valuation
Leading role in innovation
Future proof or reliable business model
Traumtanz 
20.10.20 50%
sell
Novacyt S.A.

Start price
Target price
Perf. (%)
€10.10
19.10.20
€4.00
30.10.20
14.26%
30.10.20

Probably not worthwhile Investment
marge 
19.10.20 50%
buy
Evotec SE

Start price
Target price
Perf. (%)
€23.57
19.10.20
-
04.11.21
25.20%
11.03.21

Could be worthwhile Investment >10% per year
Differentiated customer and product portfolio
Savour 
19.10.20 50%
sell
Novacyt S.A.

Start price
Target price
Perf. (%)
€10.10
19.10.20
-
04.11.21
-72.31%
05.11.21

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
shadow 
19.10.20 50%
buy
Genmark Diagnostics

Start price
Target price
Perf. (%)
€9.65
19.10.20
€12.00
02.11.20
12.95%
02.11.20

Could be worthwhile Investment >10% per year
DomRuinart 
19.10.20 50%
buy
Pacific Biosciences of California Inc.

Start price
Target price
Perf. (%)
€12.20
19.10.20
€15.00
02.11.20
-6.56%
02.11.20

Could be worthwhile Investment >10% per year
DomRuinart 
19.10.20 50%
buy
Cutera Inc.

Start price
Target price
Perf. (%)
€16.30
19.10.20
€20.00
02.11.20
-0.61%
02.11.20

Could be very worthwhile Investment >20% year
DomRuinart 
19.10.20 50%
buy
CHF Solutions Inc

Start price
Target price
Perf. (%)
-
19.10.20
€10.00
02.11.20
-
02.11.20

Could be very worthwhile Investment >20% year
DomRuinart 
19.10.20 50%
buy
Epigenomics AG NA

Start price
Target price
Perf. (%)
€0.51
18.10.20
€1.00
02.11.20
20.00%
02.11.20

Could be worthwhile Investment >10% per year
Capable Management
Very good company culture
Innovative
me8 
18.10.20 50%
sell
GNI Group Ltd

Start price
Target price
Perf. (%)
€24.00
18.10.20
€12.00
04.11.21
-35.42%
26.06.21

Probably not worthwhile Investment
Revenue decline/stagnation expected
Below average Management
Little innovation
mixitrader 
18.10.20 50%
sell
Adaptimmune Therapeutics PLC ADR

Start price
Target price
Perf. (%)
€5.70
18.10.20
€2.00
04.11.21
-35.79%
26.06.21

Probably not worthwhile Investment
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
High valuation
mixitrader 
18.10.20 50%
buy
Bayer AG

Start price
Target price
Perf. (%)
€44.90
18.10.20
€50.00
04.11.21
6.54%
12.10.21

Could be worthwhile Investment >10% per year
melinda 
18.10.20 50%
buy
Paion AG

Start price
Target price
Perf. (%)
€2.55
17.10.20
€5.00
04.11.21
-27.69%
05.11.21

Innovative
Future proof or reliable business model
Could be very worthwhile Investment >20% year
Strong uniques
kostojunior 
17.10.20 50%
buy
Cardiff Oncology Inc.

Start price
Target price
Perf. (%)
€12.90
17.10.20
-
04.11.21
-29.07%
24.03.21

Could be worthwhile Investment >10% per year
Capable Management
Top 10 in its market
Risky balance sheet
FXX 
17.10.20 50%
buy
Medigene AG

Start price
Target price
Perf. (%)
€3.51
15.10.20
€5.00
19.10.20
0.28%
19.10.20

Could be worthwhile Investment >10% per year
DomRuinart 
15.10.20 50%